跳到主要內容區塊
Close
:::
Open
10/23/2025 5:32:53 PM
  1. Home_picHome
  2. > News

Press Releases

:::
2025-10-22
  • Seminars & Lectures
  • Institute of Biomedical Sciences
Taiwan Precision Medicine Initiative Publishes Two Landmark Studies in Nature

The Taiwan Precision Medicine Initiative (TPMI), led by Academia Sinica, has established the world’s largest precision medicine research cohort of Han Chinese individuals. By integrating genetic and clinical data, the initiative has developed disease risk prediction methods across multiple conditions, laying a crucial scientific foundation for improving healthcare among more than one billion people of Han Chinese ancestry worldwide. Academia Sinica President James C. Liao emphasized that “[t]he global foundation of precision medicine has long been based primarily on data from cohorts of European descent. Through TPMI, Taiwan has built a large-scale cohort and database for disease research that reflects the genetic characteristics and their relationship to disease of Han populations. This represents not only a major scientific breakthrough but also a milestone in public health.” Partnered with 16 healthcare systems and 33 hospitals across Taiwan, the TPMI recruited over 500,000 participants to build the world’s most comprehensive genetic and clinical database for the Han populations. Using this resource, researchers have developed risk predictors for a wide range of diseases, including autoimmune diseases, cancer, cardiovascular disorders and diabetes. According to Academician Yuan-Tsong Chen, a TPMI scientific advisor, the team recently published two major papers in Nature. The first paper describes the establishment of the 500,000-person cohort and the systematic collection of medical and genetic data; the second demonstrates how large-scale biomedical data analysis can be used to develop disease risk prediction models. These publications highlight Taiwan’s scientific excellence and contributions that garnered international acclaim and opened a new chapter in disease prevention in Asian populations.

  • :
  • /233
回頂端